Every SEC Form 3/4/5 on record for this filer (CIK 1340875) — 6 issuers, 92 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ACET | Adicet Bio, Inc. | President & CEO · Director | 2020-09-17 → 2026-06-23 | 36 | −$5M |
| KPTI | Karyopharm Therapeutics Inc. | Director | 2020-11-30 → 2026-05-26 | 8 | — |
| TORC | resTORbio, Inc. | President and CEO · Director · lapsed | 2018-01-25 → 2019-12-06 | 7 | $53,540 |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | Director · lapsed | 2017-11-13 → 2018-12-21 | 3 | — |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Former President and CEO · Director · lapsed | 2016-07-22 → 2016-07-22 | 1 | — |
| SNTA | SYNTA PHARMACEUTICALS CORP | President and CEO · Director · lapsed | 2015-09-18 → 2015-10-06 | 2 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ACET | 2023-10-02 | Buy | 5,500 | $1.33 | $7,315 | 43,469 |
| ACET | 2023-09-29 | Sell | 5,500 | $1.36 | $7,480 | 176,969 |
| ACET | 2023-09-28 | Buy | 5,500 | $1.42 | $7,810 | 182,469 |
| ACET | 2023-09-28 | Sell | 5,500 | $1.42 | $7,810 | 37,969 |
4 of 6 issuers are covered and open a security page; the rest are on file here only.
